The following trials provide information to treat various types of disease of the brain and the central and local nervous systems, both for ongoing and completed clinical trials. For more information on this therapy area please click here.
- collapse A 26-week, International, Multicenter, Open-label Phase IIIb Study of the Safety and Tolerability of Quetiapine Fumarate (SEROQUEL) Immediate-release Tablets in Daily Doses of 400 mg to 800 mg in Children and Adolescents with Bipolar I Disorder and Adolescents with Schizophrenia
- collapse A Multicenter, Double-blind, Randomized, Placebo-controlled, Phase IV Study of the Safety and Efficacy of Lithium versus Placebo as an add on to SEROQUEL XR (Quetiapine Fumarate) in Adult Patients with Acute Mania
- collapse NIS to Observe Improvement in Global Assessment of Functioning in Patients With Schizophrenia
- collapse Seroquel Safety Study
- collapse Determine Central 5-HT1B Receptor Occupancy of ZOMIG® Rapimelt (Zolmitriptan) in Healthy Male Volunteers
- collapse Patient Satisfaction and Quality of Life under Treatment with Seroquel XR
- collapse Observational Study to Evaluate Efficacy and Remission Status for Schizophrenia Patients Under Atypical Treatment
- collapse The purpose of the study is to gain an in-depth picture of the patient management and prescription behaviours
- collapse A study evaluating the treatment selection and outcome when changing antipsychotic treatment in schizophrenic patients.
- collapse Seroquel XR in schizophrenia relapse prevention
